Staging in Esophageal and Gastric Cancers.

View/ Open
Date
2017-06Author
Hayes, T
Smyth, E
Riddell, A
Allum, W
Type
Journal Article
Metadata
Show full item recordAbstract
Gastric and esophageal tumors have a poor prognosis; approximately 15% of patients are alive at 10 years following diagnosis. Surgical resection plus adjunctive chemotherapy or chemoradiotherapy is curative in approximately 50% of patients with operable disease, but is also associated with significant morbidity. Therefore, accurate preoperative staging is required to spare patients unnecessary toxicity and futile surgery. This review evaluates the sensitivity and specificities of the modalities used to stage patients with gastroesophageal cancer. Staging techniques reviewed include CT, PET, MRI, EUS, and laparoscopy. The article concludes with suggestions on appropriate staging tools according to site and stage of disease.
Collections
Subject
Animals
Humans
Esophageal Neoplasms
Stomach Neoplasms
Neoplasm Metastasis
Positron-Emission Tomography
Tomography, X-Ray Computed
Neoplasm Staging
Language
eng
License start date
2017-06
Citation
Hematology/oncology clinics of North America, 2017, 31 (3), pp. 427 - 440